Combination treatment of multiple sclerosis (ms) other...

Details Combination treatment of multiple sclerosis (ms) other... Combination treatment of multiple sclerosis (ms) other...

A - Human Necessities

61

K

A61K 31/54 (2006.01) A61K 31/135 (2006.01) A61K 31/165 (2006.01) A61K 31/381 (2006.01) A61K 31/40 (2006.01) A61K 31/4015 (2006.01) A61K 31/405 (2006.01) A61K 31/41 (2006.01) A61K 31/4164 (2006.01) A61K 31/4166 (2006.01) A61K 31/4192 (2006.01) A61K 31/4196 (2006.01) A61K 31/42 (2006.01) A61K 31/426 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61K 31/513 (2006.01) A61K 31/5375 (2006.01) A61K 45/06 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2380381

The present invention relates to a method of treating Multiple Sclerosis; other demyelinating disorders and peripheral neuropathy in a mammal by administering to the mammal a neurotransmitter-inducing or precursor agent in combination with a Serotonin Reuptake Inhibitor (SRI) antidepressant or an anxiolytic agent with improvement in efficiency. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a neurotransmitter-inducing or precursor agent, and an SRI antidepressant or anxiolytic agent.

Affiliated with

Also associated with

Rating

Combination treatment of multiple sclerosis (ms) other... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination treatment of multiple sclerosis (ms) other..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination treatment of multiple sclerosis (ms) other... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1924788